Greenlight Capital Re: Loss Reduction and Favorable Valuation Metrics Amid Ongoing Unprofitability

Greenlight Capital Re's annual losses have narrowed by 25.2% over the past five years, despite ongoing unprofitability. The stock trades at a discounted Price-To-Sales ratio of 0.6x, lower than its peer group average of 4.9x and the US insurance industry's 1.1x. The company's current share price of $11.95 is below the DCF fair value estimate of $20.06, sparking interest in re-rating potential if improvement persists.